Aytu BioPharma Inc. (AYTU)
NASDAQ: AYTU
· Real-Time Price · USD
1.86
-0.20 (-9.71%)
At close: Sep 25, 2025, 3:59 PM
1.81
-2.69%
After-hours: Sep 25, 2025, 04:21 PM EDT
-9.71% (1D)
| Bid | 1.8 |
| Market Cap | 11.68M |
| Revenue (ttm) | 69.22M |
| Net Income (ttm) | 1.64M |
| EPS (ttm) | -1.49 |
| PE Ratio (ttm) | -1.25 |
| Forward PE | -3.51 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.93 |
| Volume | 537,861 |
| Avg. Volume (20D) | 179,830 |
| Open | 2.07 |
| Previous Close | 2.06 |
| Day's Range | 1.82 - 2.09 |
| 52-Week Range | 0.95 - 2.85 |
| Beta | 0.23 |
| Ex-Dividend Date | n/a |
About AYTU
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AYTU
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AYTU stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Aytu BioPharma has released their quartely earnings
on Sep 23, 2025:
Aytu BioPharma Inc. is scheduled to release its earnings on
Nov 12, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 day ago
-17.93%
Aytu BioPharma shares are trading lower after the ...
Unlock content with
Pro Subscription
2 days ago
+0.8%
Aytu BioPharma shares are trading lower after the company reported worse-than-expected Q4 financial results.
